| |
Controls (n = 20)
|
Patients (n = 15)
|
p
|
|---|
|
LV-EF (%)
|
65 ± 4
|
68 ± 7
|
0.24
|
|
LV-EDV (ml)
|
109 ± 27
|
118 ± 28
|
0.57
|
|
LV-ESV (ml)
|
39 ± 13
|
39 ± 14
|
0.91
|
|
LV-SV
|
71 ± 15
|
80 ± 20
|
0.19
|
|
LV-EDD
|
45 ± 5
|
47 ± 4
|
0.36
|
|
LA (cm2)
|
20 ± 3
|
20 ± 3
|
0.71
|
|
IVS (mm)
|
10 ± 2
|
11 ± 2
|
0.11
|
|
PA (mm)
|
24 ± 4
|
24 ± 4
|
0.78
|
|
LV mass (g)
|
85 ± 20
|
92 ± 25
|
0.57
|
|
LGE per patient
|
-
|
7 (47%)
| |
|
epicardial
|
-
|
3 (20%)
| |
|
intramural
|
-
|
4 (27%)
| |
|
transmural
|
-
|
-
| |
|
subendocardial
|
-
|
-
| |
|
% LV mass
|
-
|
6.3 ± 4
| |
|
Native T1 (ms)
|
952 (923–960)
|
1002 (972–1023)
|
<0.001
|
|
Post-contrast T1 (ms)
|
524 (500–529)
|
490 (477–551)
|
0.16
|
|
ECV (%)
|
24.5 (23–25)
|
27 (26–28)
|
<0.001
|
|
T2 (ms)
|
49 (48–51)
|
53 (51–54)
|
<0.001
|
- All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume
